MedPath

Nebiloc CCB

Brand Name: Nebiloc CCB

Generic Name: Nebivolol (as Hydrochloride) + Amlodipine (as Besilate)

Active
Registration Number

DR-XY38965

Dosage Form

Tablet

Issuance Date

October 31, 2023

Expiry Date

January 17, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength5mg/5mg
PackagingAlu/Alu Blister Pack of 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Beta Blocker-Calcium Channel Blocker Combination
A
Application
Automatic Renewal (E-AR)
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Nebivolol (as Hydrochloride)Active
Amlodipine (as Besilate)Active

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.